Antibe Therapeutics Inc.

(ATE:CA)

By |

Profile

Antibe Therapeutics Inc is a human drug development company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen.

Contact Information

Website: www.antibethera.com
Main Phone: +1 905 726-0995
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: CDX
NAICS: Pharmaceutical P
$ 0.16 ($ 0.01) (-3.03%)
Last Price 0.16 Change $ -0.01 Change % -3.03 Tick N/A
Bid 0.16 Bid Size 15,500.00 Ask 0.18 Ask Size 54,500.00
Open 0.18 High 0.18 Low 0.16 Prev Close 0.17
Last Trade Volume 69,000 52 Wk Hi 0.27 52 Wk Low 0.11
Market Cap 15 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 93,518,615.00 EPS (TTM) -0.05 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.4 0.4 0.4 0.4
Low Target Price Estimate 0.4 0.4 0.4 0.4
Mean Target Price Estimate 0.4 0.4 0.4 0.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/11/16 04/11/16 04/11/16 04/11/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1